Binding of translationally controlled tumour protein to the N-terminal domain of HDM2 is inhibited by Nutlin-3
Translationally Controlled Tumour Protein (TCTP), a highly conserved protein present in all eukaryotic organisms, has a number of intracellular and extracellular functions including an anti-apoptotic role. TCTP was recently shown to interact with both p53 and HDM2, inhibiting auto-ubiquitination of...
Main Authors: | Funston, Garth., Goh, Walter., Wei, Siau Jia., Tng, Quah Soo., Tong, Loh Jiah., Verma, Chandra Shekhar., Ghadessy, Farid., Lane, David P., Brown, Christopher J. |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Journal Article |
Language: | English |
Published: |
2013
|
Online Access: | https://hdl.handle.net/10356/95362 http://hdl.handle.net/10220/9204 |
Similar Items
-
In vitro selection of mutant HDM2 resistant to nutlin inhibition
by: Wei, Siau Jia., et al.
Published: (2014) -
Inhibition of nutlin-resistant HDM2 mutants by stapled peptides.
by: Siau Jia Wei, et al.
Published: (2013-01-01) -
Structure of a stapled peptide antagonist bound to nutlin-resistant Mdm2
by: Chee, Sharon Min Qi, et al.
Published: (2014) -
HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (<it>cis</it>-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas
by: Sosin Angela M, et al.
Published: (2012-09-01) -
The effect of molecular shape on oligomerization of hydrophobic drugs : molecular simulations of ciprofloxacin and nutlin
by: Li, Jianguo, et al.
Published: (2019)